XML 36 R13.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes
12 Months Ended
Dec. 31, 2024
Income Taxes [Abstract]  
Income Taxes
Note 6 – Income Taxes

UTG and UG file separate federal income tax returns.

Income tax expense (benefit) consists of the following components:

 
2024
   
2023
 
Current tax expense (benefit)
 
$
2,107,419
   
$
(517,109
)
Deferred tax
   
10,711,564
     
558,916
 
Income tax expense
 
$
12,818,983
   
$
41,807
 

The expense for income taxes differed from the amounts computed by applying the applicable United States statutory rate of 21% as of December 31, 2024 and 2023, before income taxes as a result of the following differences:

 
2024
   
2023
 
Tax computed at statutory rate
 
$
13,066,234
   
$
590,481
 
Changes in taxes due to:
               
Non-controlling interest
   
(20,930
)
   
(23,813
)
Dividend received deduction
   
(143,534
)
   
(109,642
)
Oil and gas royalty's depletion
   
(104,115
)
   
(106,797
)
Other, including prior year true up
   
21,328
     
(308,422
)
Income tax expense
 
$
12,818,983
   
$
41,807
 

The following table summarizes the major components that comprise the net deferred tax liability as reflected in the balance sheets:

 
2024
   
2023
 
Investments
 
$
23,066,656
   
$
11,862,470
 
Cost of insurance acquired
   
294,227
     
427,748
 
Management/consulting fees
   
(7,596
)
   
(7,899
)
Future policy benefits
   
(600,175
)
   
(697,024
)
Deferred gain on sale of subsidiary
   
1,387,490
     
1,387,490
 
Other liabilities
   
(786,095
)
   
(284,350
)
Reserves adjustment
   
48,051
     
96,105
 
Federal tax DAC
   
(229,697
)
   
(236,950
)
Loan loss reserve
   
(100,800
)
   
(120,750
)
Deferred tax liability
 
$
23,072,061
   
$
12,426,840
 

At December 31, 2024 and 2023, the Company had gross deferred tax assets of $2,175,830 and $1,939,816, respectively, and gross deferred tax liabilities of $25,247,891 and $14,366,656, respectively, resulting from temporary differences primarily related to the life insurance subsidiary.  A valuation allowance is to be provided when it is more likely than not that deferred tax assets will not be realized by the Company. No valuation allowance has been recorded relating to the Company’s deferred tax assets since, in Management’s judgment, the Company will more likely than not have sufficient taxable income in future periods to fully realize its existing deferred tax assets.

The Company’s Federal income tax returns are periodically audited by the Internal Revenue Service (“IRS”). There are currently no examinations in process, nor is Management aware of any pending examination by the IRS.  The Company follows the accounting guidance for uncertainty in income taxes using the provisions of Financial Accounting Standards Board (“FASB”) ASC 740, Income Taxes. Using that guidance, tax positions initially need to be recognized in the financial statements when it is more-likely-than-not the position will be sustained upon examination by the tax authorities. Such tax positions initially and subsequently need to be measured as the largest amount of tax benefit that has a greater than 50% likelihood of being realized upon ultimate settlement with the tax authority assuming full knowledge of the position and relevant facts. The Company has evaluated its tax positions, expiring statutes of limitations, changes in tax law and new authoritative rulings and believes that no disclosure relative to a provision of income taxes is necessary, at this time, to cover any uncertain tax positions. Tax years that remain subject to examination are the years ended December 31, 2021, 2022, 2023, 2024.

The Company classifies interest and penalties on underpayment of income taxes as income tax expense.  No interest or penalties were included in the reported income taxes for the years presented.  The Company is not aware of any potential or proposed changes to any of its tax filings.